Skip to content

The Medial Prefrontal Cortex Modulates Psychedelic-like Effects of Psilocin

Miyuan Zhang, Haiyan Zhai, Liu Yang, Haohong Li, Xiaohui Wang

ACS Pharmacology & Translational Science July 8, 2025 DOI: 10.1021/acsptsci.5c00324 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Experimental study Peer reviewed
Population Male mice
Intervention Psilocin
Dose picomolar dose
Measures Head twitch response (HTR), c-Fos immunofluorescent labeling
Topics Psilocybin
Keywords Prefrontal cortex Consumer neuroscience
Citations 1
Key findings The medial prefrontal cortex (mPFC) is a critical regulator of psilocin-induced psychedelic-like behavior, as demonstrated by c-Fos labeling and optogenetic manipulation in male mice.

Abstract

Recent advancements in the study of psilocybin and its active metabolite psilocin have highlighted their unique psychedelic properties and potential therapeutic applications, particularly in the rapid and sustained treatment of depression. However, the potent acute psychedelic effects of psilocybin necessitate a deeper understanding of the neural mechanisms underlying its action. In this study, we investigated the psilocin-induced neural activity in male mice using c-Fos immunofluorescent labeling and identified brain regions associated with psychedelic-like activity. Among the medial prefrontal cortex (mPFC), orbitofrontal cortex (OFC), interstitial nucleus of the posterior limb of the anterior commissure (IPAC), and dorsomedial striatum (DMS), only the mPFC was specifically associated with the head twitch response (HTR), a hallmark of psychedelic-like behavior. A picomolar dose of psilocin in the mPFC was sufficient to induce significant HTR, suggesting that c-Fos-positive neurons in this region modulate psychedelic-like activity. To validate this hypothesis, optogenetic activation of these neurons significantly increased spontaneous HTR in TRAP2 mice, whereas acute inhibition suppressed drug-induced HTR. These findings establish the mPFC as a critical regulator of psilocin-induced psychedelic-like activity and provide valuable insights for enhancing the clinical safety and therapeutic application of psychedelics.